Skip to main content
Premium Trial:

Request an Annual Quote

DNANexus Signs Agreements with Geisinger Health System, UCSF

Premium

DNANexus said this week that it has signed an agreement with Geisinger Health System that should yield clinically relevant workflows for the use of genome sequence data in medicine.

Specifically, scientists in Geisinger's Clinical Program for Whole Genome Sequencing will have access to DNANexus' genomic data management capabilities, including data visualization, analysis, and storage.

In turn, Geisinger will counsel the company on the use of WGS data in clinical settings, and on ways to extend DNANexus' capabilities to further support such activities, the company said.

Simultaneously, DNANexus said that researchers at the University of California, San Francisco, will use its cloud platform to upload, store, and analyze their sequence data.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more